← back to search

Yunxia Zhang

Jiangnan University · CN
Area of research
Internal Medicine · Pulmonary and Respiratory Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Pulmonary Hypertension Research and Treatments, COVID-19 Clinical Research Studies, and MicroRNA in disease regulation.
h-index
24
citations
1,877
works
133
NIH funding
primary concept
email

Recent publications

One stop shop V: taxonomic update with molecular phylogeny for important phytopathogenic genera: 101–125 (2024)
Fungal Diversity 2025cited by 11position: middledoi
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCC
Future Oncology 2025cited by 3position: middledoi
Development of a lung perfusion automated quantitative model based on dual-energy CT pulmonary angiography in patients with chronic pulmonary thromboembolism
Insights into Imaging 2025cited by 3position: middledoi
Leukocyte Count as an In‐Hospital Prognostic Indicator in Acute Pulmonary Embolism: Evidence From a Registry Study and Genetic Analyses
Respirology 2025cited by 1position: middledoi
2125P A phase II study of simmitinib in combination with liposomal irinotecan for second-line treatment of advanced esophageal squamous cell carcinoma
Annals of Oncology 2025cited by 0position: lastdoi
Serum proteome profiling reveals heparanase as a candidate biomarker for chronic thromboembolic pulmonary hypertension
iScience 2024cited by 25position: firstdoi
A new integrative analysis of histopathology and single cell RNA-seq reveals the CCL5 mediated T and NK cell interaction with vascular cells in idiopathic pulmonary arterial hypertension
Journal of Translational Medicine 2024cited by 14position: middledoi
Serum proteome profiling reveals HGFA as a candidate biomarker for pulmonary arterial hypertension
Respiratory Research 2024cited by 3position: middledoi
Risk of bleeding in pulmonary embolism patients concomitant with COVID-19 undergoing extended anticoagulation: A multicenter cohort study
Thrombosis Research 2024cited by 2position: middledoi
Le miR-224-5p régulé sert de biomarqueur pour l’insuffisance hépatique aiguë pédiatrique et régule l’inflammation en modulant ZBTB20
Annales de biologie clinique 2024cited by 1position: middledoi
Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development
Journal of Human Genetics 2023cited by 43position: middledoi
Clinical Phenotypes With Prognostic Implications in Pulmonary Embolism Patients With Syncope
Frontiers in Cardiovascular Medicine 2022cited by 9position: middledoi
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study
Thrombosis Journal 2022cited by 8position: middledoi
Clinical features and metabolic reprogramming of atherosclerotic lesions in patients with chronic thromboembolic pulmonary hypertension
Frontiers in Cardiovascular Medicine 2022cited by 7position: middledoi
Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pUlmonary thromboembolism REgistry Study (CURES)
European Respiratory Journal 2021cited by 57position: middledoi
Circular RNA cir‐ITCH Is a Potential Therapeutic Target for the Treatment of Castration‐Resistant Prostate Cancer
BioMed Research International 2020cited by 23position: middledoi
Rational and design of the China Pulmonary Thromboembolism Registry Study (CURES): A prospective multicenter registry
International Journal of Cardiology 2020cited by 16position: middledoi
Genetic association of ADAM33 polymorphisms with childhood asthma in Chinese Han population
Medicine 2019cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wanmu Xie · Chinese Academy of Medical Sciences & Peking Union Medical College10 papers (2020–2025)Zhenguo Zhai · Academy of Medical Sciences7 papers (2020–2024)Linfeng Xi · Harbin Medical University6 papers (2023–2025)Yishan Li · Shanxi Medical University6 papers (2022–2025)Zhu Zhang · Hong Kong Baptist University6 papers (2020–2025)Dingyi Wang · Fujian Normal University5 papers (2020–2025) · 5 papers (2022–2024)Qian Gao · Nanjing University of Chinese Medicine4 papers (2020–2024)Xiaomao Xu · Harbin Medical University4 papers (2020–2025)Jieping Lei · China-Japan Friendship Hospital4 papers (2020–2025)Baomin Fang · Dalian Medical University4 papers (2020–2025) · 4 papers (2020–2025)Yingqun Ji · Fudan University4 papers (2020–2025)Qun Yi · Dalian Medical University4 papers (2020–2025) · 4 papers (2020–2025)Jun Wan · Chinese Academy of Sciences3 papers (2020–2025)Xincheng Li · Erasmus MC3 papers (2024–2024)Shuangshuang Ma · Allen Institute for Brain Science3 papers (2022–2024) · 3 papers (2020–2022) · 3 papers (2024–2025)